Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01460914 |
Recruitment Status :
Active, not recruiting
First Posted : October 27, 2011
Last Update Posted : May 5, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cutaneous T Cell Lymphoma Graft Versus Host Disease |
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Outcomes of Cutaneous T-Cell Lymphoma and Chronic Graft-Versus-Host Disease in Patients Treated With Extracorporeal Photopheresis |
Study Start Date : | October 2011 |
Estimated Primary Completion Date : | September 2050 |
Estimated Study Completion Date : | October 2050 |

- Response rates [ Time Frame: 1 year ]Response rates to ECP treatment
- Complications [ Time Frame: 1 year ]Complications to ECP procedures

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients who receive Extracorporeal Photopheresis treatment
- Treated at Dartmouth-Hitchcock Medical Center
- Must be 18 years or older
Exclusion Criteria:
- None specified

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01460914
United States, New Hampshire | |
Dartmouth-Hitchcock Medical Center | |
Lebanon, New Hampshire, United States, 03756 |
Principal Investigator: | Frederick Lansigan, MD | Dartmouth-Hitchcock Medical Center |
Responsible Party: | Frederick Lansigan, Assistant Professor of Medicine, Dartmouth-Hitchcock Medical Center |
ClinicalTrials.gov Identifier: | NCT01460914 |
Other Study ID Numbers: |
D11271 |
First Posted: | October 27, 2011 Key Record Dates |
Last Update Posted: | May 5, 2020 |
Last Verified: | May 2020 |
ECP CTCL Extracorporeal photopheresis |
Cutaneous T Cell Lymphoma GVHD Graft versus host disease |
Lymphoma Lymphoma, T-Cell Lymphoma, T-Cell, Cutaneous Graft vs Host Disease Neoplasms by Histologic Type Neoplasms |
Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases Lymphoma, Non-Hodgkin |